Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 2/2001

Inhalt (8 Artikel)

ORIGINAL ARTICLE

Generation of human anti-MUC3 IgG antibodies after in vitro immunization of naive peripheral blood B-lymphocytes

Stavroula Baritaki, Alexandros Zafiropoulos, Eustathia Georgopoulou, Sotirios Souris, Elias Krambovitis

ORIGINAL ARTICLE

Active idiotypic vaccination in a patient with biclonal follicular lymphoma

Yvelise Barrios, Aresio Plaza, Rafael Cabrera, Rosa Yáñez, Eduardo Suárez, Manuel Nicolás Fernández, Fernando Díaz-Espada

ORIGINAL ARTICLE

Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system

Christoph Renner, Ingo Stehle, Fook Thean Lee, Cathrine Hall, Bruno Catimel, Edouard C. Nice, Angela Mountain, Angela Rigopoulos, Martin W. Brechbiel, Michael Pfreundschuh, Andrew M. Scott

ORIGINAL ARTICLE

Human scFv antibody fragments specific for the epithelial tumour marker MUC-1, selected by phage display on living cells

Cindy Wong, Robert Waibel, Michael Sheets, Jean-Pierre Mach, Ricarda Finnern

ORIGINAL ARTICLE

Long-term treatment with low doses of interleukin-2 and interferon-α: immunological effects in advanced renal cell cancer

Laura Pavone, Simeone Andrulli, Rosaria Santi, Maria Majori, Carlo Buzio

ORIGINAL ARTICLE

Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images

Aiden A. Flynn, Geoffrey M. Boxer, Richard H. J. Begent, R. Barbara Pedley

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.